SplitJul 13, 2026, 04:37 PM
Apimeds Pharmaceuticals US to effect 1-for-10 reverse stock split
AI Summary
Apimeds Pharmaceuticals US, Inc. announced that its 1-for-10 reverse stock split will become effective on July 24, 2026, at 12:01 a.m. Eastern Time. This revised effective date replaces the previously announced March 26, 2026. Stockholders approved the split on December 1, 2025, and the company's common stock is expected to begin trading on a split-adjusted basis on the NYSE American LLC under the symbol "APUS" at the open of trading on July 24, 2026.
Key Highlights
- Stockholders approved a 1-for-10 reverse stock split on December 1, 2025.
- The reverse stock split will become effective on July 24, 2026, at 12:01 a.m. Eastern Time.
- This new effective date replaces the previously announced March 26, 2026.
- Common stock will begin trading on a split-adjusted basis on NYSE American under "APUS" on July 24, 2026.
- Every ten shares of common stock will automatically be combined into one share.
- The new CUSIP number for the common stock following the split will be 03771D201.
Price Impact
More from APUS